Vilin Bio Med (NSE:VILINBIO) LT-Debt-to-Total-Asset : 0.01 (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Vilin Bio Med's long-term debt to total assests ratio for the quarter that ended in Sep. 2023 was 0.01.

Vilin Bio Med's long-term debt to total assets ratio declined from Mar. 2022 (0.05) to Sep. 2023 (0.01). It may suggest that Vilin Bio Med is progressively becoming less dependent on debt to grow their business.

Vilin Bio Med LT-Debt-to-Total-Asset Historical Data

The historical data trend for Vilin Bio Med's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med LT-Debt-to-Total-Asset Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

LT-Debt-to-Total-Asset

0.07

0.05

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
LT-Debt-to-Total-Asset	-	0.07	0.05	-	0.01

Vilin Bio Med LT-Debt-to-Total-Asset Calculation

Vilin Bio Med's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2022 is calculated as

LT Debt to Total Assets (A: Mar. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2022 )	/	Total Assets (A: Mar. 2022 )
	=	7.34	/	135.583
	=	0.05

Vilin Bio Med's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

LT Debt to Total Assets (Q: Sep. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2023 )	/	Total Assets (Q: Sep. 2023 )
	=	2.525	/	309.444
	=	0.01

Vilin Bio Med (NSE:VILINBIO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Vilin Bio Med LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines